Forecast

There is no analyst data available for this company.

News Go to news feed

Vidac Pharma board member sells 10,000 shares at €0.40

Dr. Max Herzberg, board member of Vidac Pharma, sold a total of 10,000 shares on 10 September 2026 at €0.40 each; the transaction was disclosed on 14 September 2026. Earlier on 10 September 2026, Herzberg had already reported a reduction of 5,061 shares at €0.41. The stock showed little reaction and was last trading on the FSE around €0.38–0.40; the market capitalization is about €20.55 million. » More on finanzen.net
Executive Dr. Max Herzberg reduces Vidac Pharma stake

Dr. Max Herzberg, a board member at Vidac Pharma, on 10 September 2026 initially sold 5,061 shares at €0.41 each; the transaction was reported to BaFin on 14 September 2026. Earlier the same day he had already disposed of 10,000 shares at €0.40 each. The Vidac Pharma share showed little movement and closed on the FSE at €0.38; market capitalization is about €20.55 million. » More on finanzen.net
Board member Herzberg sells Vidac Pharma shares: 12,500 units at €0.43

On 01.09.2026, board member Dr. Max Herzberg reported the sale of 12,500 Vidac Pharma shares at €0.43 each; the transaction was received by BaFin on 03.09.2026. Previously, Herzberg had already disposed of 10,000 shares at €0.42. The Vidac Pharma share was unchanged at €0.41 in FSE trading; market capitalization is around €20.91 million with 51,625,060 freely tradable shares. » More on finanzen.net